Travere Therapeutics, Inc.
TVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438533
In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Travere Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- −14 vs. Q1 2021
- Shares held
- 61.3M
- −1.36M (−2.2%) vs. Q1 2021
- Total value
- $900.8M
- −$662.9M (−42.4%) vs. Q1 2021
- New holders
- 22
- 50 more added
- Sold out
- 36
- 43 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $5.98B |
| Q1 2026 | 261 | $3.01B |
| Q4 2025 | 278 | $3.90B |
| Q3 2025 | 238 | $2.41B |
| Q2 2025 | 213 | $1.49B |
| Q1 2025 | 218 | $1.77B |
| Q4 2024 | 197 | $1.66B |
| Q3 2024 | 178 | $1.16B |
| Q2 2024 | 174 | $723.4M |
| Q1 2024 | 175 | $677.4M |
| Q4 2023 | 165 | $769.6M |
| Q3 2023 | 169 | $737.2M |
| Q2 2023 | 169 | $1.27B |
| Q1 2023 | 175 | $1.89B |
| Q4 2022 | 155 | $1.53B |
| Q3 2022 | 171 | $1.72B |
| Q2 2022 | 171 | $1.68B |
| Q1 2022 | 169 | $1.79B |
| Q4 2021 | 169 | $2.04B |
| Q3 2021 | 148 | $1.48B |
| Q2 2021 | 136 | $900.8M |
| Q1 2021 | 150 | $1.56B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Travere Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eaton Vance Management | 177,721 | $2.59M | 0.00% | +135,606+322.0% | Added |
| Baker Bros. Advisors LP | 186,915 | $2.73M | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 203,454 | $2.97M | 0.00% | −2,958−1.4% | Reduced |
| Citigroup Inc | 210,519 | $3.07M | 0.00% | +85,578+68.5% | Added |
| Wells Fargo & Company | 210,626 | $3.07M | 0.00% | +59,518+39.4% | Added |
| Tekla Capital Management LLC | 212,869 | $3.11M | 0.10% | 00.0% | Unchanged |
| Healthcare of Ontario Pension Plan Trust Fund | 272,000 | $3.97M | 0.01% | +272,000 | New |
| Mangrove Partners | 295,037 | $4.30M | 0.47% | +295,037 | New |
| GW&K Investment Management, LLC | 314,749 | $4.59M | 0.04% | −6,485−2.0% | Reduced |
| Deutsche Bank AG | 341,929 | $4.99M | 0.00% | −104,640−23.4% | Reduced |
| Pictet Asset Management Ltd | 352,423 | $5.14M | 0.01% | +222,262+170.8% | Added |
| Canada Pension Plan Investment Board | 358,000 | $5.22M | 0.01% | +358,000 | New |
| Laurion Capital Management LP | 567,183 | $8.28M | 0.13% | +304,170+115.6% | Added |
| Northern Trust Corp | 618,745 | $9.03M | 0.00% | −22,176−3.5% | Reduced |
| Charles Schwab Investment Management Inc | 640,115 | $9.34M | 0.00% | −35,535−5.3% | Reduced |
| Manufacturers Life Insurance Company, The | 709,502 | $10.4M | 0.01% | −1,600,385−69.3% | Reduced |
| Jacobs Levy Equity Management, Inc | 790,931 | $11.5M | 0.08% | +149,759+23.4% | Added |
| Geode Capital Management, LLC | 1,005,439 | $14.7M | 0.00% | +48,193+5.0% | Added |
| JPMorgan Chase & Co | 1,056,524 | $15.4M | 0.00% | +1,027,538+3,544.9% | Added |
| Great Point Partners LLC | 1,084,300 | $15.8M | 3.54% | +490,588+82.6% | Added |
| Nuveen Asset Management, LLC | 673,317 | $16.6M | 0.00% | −193,909−22.4% | Reduced |
| Dimensional Fund Advisors LP | 1,146,826 | $16.7M | 0.01% | −84,684−6.9% | Reduced |
| D. E. Shaw & Co., Inc. | 1,197,798 | $17.5M | 0.02% | −278,681−18.9% | Reduced |
| Rock Springs Capital Management LP | 1,494,164 | $21.8M | 0.43% | +18,600+1.3% | Added |
| Bank of America Corp | 1,672,485 | $24.4M | 0.00% | −763,586−31.3% | Reduced |
| Renaissance Technologies LLC | 1,711,322 | $25.0M | 0.03% | +122,600+7.7% | Added |
| Perceptive Advisors LLC | 1,845,555 | $26.9M | 0.35% | −1,452,864−44.0% | Reduced |
| Goldman Sachs Group Inc | 2,457,280 | $35.9M | 0.01% | +1,629,846+197.0% | Added |
| State Street Corp | 3,453,859 | $50.4M | 0.00% | +1,014,332+41.6% | Added |
| Adage Capital Partners GP, L.L.C. | 3,593,763 | $52.4M | 0.10% | −956,237−21.0% | Reduced |
| Vanguard Group Inc | 3,834,756 | $55.9M | 0.00% | −166,832−4.2% | Reduced |
| Janus Henderson Group PLC | 3,905,113 | $57.0M | 0.02% | −245,443−5.9% | Reduced |
| Macquarie Group Ltd | 3,912,413 | $57.1M | 0.05% | +1,174,860+42.9% | Added |
| BlackRock Inc. | 4,992,525 | $72.8M | 0.00% | +160,970+3.3% | Added |
| Ra Capital Management, L.P. | 5,614,428 | $81.9M | 1.31% | 00.0% | Unchanged |
| Armistice Capital, LLC | 5,748,000 | $83.9M | 2.23% | +3,392,000+144.0% | Added |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,608,126−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −1,249,000−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −618,520−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −528,100−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −247,011−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −220,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −174,193−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −125,900−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −102,633−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −99,500−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −82,981−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −58,152−100.0% | Sold out |
| Jackson Creek Investment Advisors LLC | 0 | $0 | 0.00% | −42,055−100.0% | Sold out |
| Mackay Shields LLC | 0 | $0 | 0.00% | −41,927−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −38,125−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −33,550−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −28,813−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −23,496−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −18,615−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −14,635−100.0% | Sold out |
| Calton & Associates, Inc. | 0 | $0 | 0.00% | −10,098−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −8,025−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −8,608−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −2,293−100.0% | Sold out |
| Exane Derivatives | 0 | $0 | 0.00% | −1,706−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −1,447−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −728−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −11−100.0% | Sold out |